FMS Fresenius Medical Care AG IFRS
Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 1333141 · Reporting currency EUR
Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY1.5%
TTM net income YoY81.9%
TTM EPS YoY83.6%
Revenue 3-yr CAGR0.4%
Net income 3-yr CAGR13.3%
Margins
Gross margin25.6%
Operating margin9.3%
Net margin5.0%
FCF margin—
EBITDA margin16.8%
Returns
ROE7.0%
ROA3.0%
ROIC (approx.)7.3%
Asset turnover0.61x
Leverage & solvency
Liabilities / assets53.9%
Debt / equity0.55x
Current ratio1.26x
Interest coverage4.87x
Cash quality & payout
Operating cash flow / net income2.74x
Accruals ratio-5.3%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: EUR | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | 19.63B | 19.34B |
| Cost of revenue | 14.60B | 14.58B |
| Gross profit | 5.03B | 4.76B |
| R&D expense | 157.97M | 183.49M |
| SG&A expense | 3.03B | 3.14B |
| Operating income | 1.83B | 1.39B |
| Interest expense | 375.22M | 393.32M |
| Pretax income | 1.51B | 1.06B |
| Income tax | 320.97M | 316.06M |
| Net income | 978.37M | 537.91M |
| EBITDA | 3.29B | 2.93B |
| EPS (basic) | 3.36 | 1.83 |
| EPS (diluted) | 3.36 | 1.83 |
| Banking | ||
| Net interest income | -314.80M | -335.47M |
| Balance sheet | ||
| Cash & equivalents | 1.60B | 1.18B |
| Inventory | 2.14B | 2.07B |
| Current assets | 7.90B | 7.92B |
| PP&E, netmay include right-of-use assets (IFRS) | 3.49B | 3.65B |
| Goodwill | 13.57B | 15.17B |
| Intangibles | 1.25B | 1.37B |
| Total assets | 31.00B | 33.57B |
| Current liabilities | 6.25B | 5.66B |
| Short-term debt | 1.60B | 575.28M |
| Long-term debt | 5.69B | 6.26B |
| Total debt | 7.29B | 6.84B |
| Total liabilities | 16.72B | 17.80B |
| Shareholders' equity | 13.31B | 14.58B |
| Net debt | 5.69B | 5.66B |
| Shares outstanding | 279.29M | 293.41M |
| Cash flow statement | ||
| Operating cash flow | 2.68B | 2.39B |
| Investing cash flow | -722.53M | -84.94M |
| Financing cash flow | -1.40B | -2.57B |
| Depreciation & amortization | 1.46B | 1.54B |
| Dividends paid | 422.51M | 349.16M |
| Share buybacks | 585.28M | — |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· Amounts are in the company's reporting currency, EUR, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.